The Significance of TNF-α and MMP-8 Concentrations in Non-invasively Obtained Amniotic Fluid Predicting Fetal Inflammatory Response Syndrome
Overview
Authors
Affiliations
Objective: To determine the significance of tumor necrosis factor-α (TNF-α) and matrix metalloproteinase-8 (MMP-8) in vaginally obtained amniotic fluid predicting fetal inflammatory response syndrome (FIRS) after preterm premature rupture of membranes (PPROM).
Methods: In this prospective case-control study, TNF-α and MMP-8 concentrations were evaluated in vaginally obtained amniotic fluid from women with PPROM at 22-34 weeks of pregnancy. Biomarkers' concentrations were determined using an enzyme-linked immunosorbent assay. Patients were divided into two groups: the FIRS group (cord blood interleukin-6 > 11 pg/ml or histological funisitis) and the non-FIRS group (without these findings). The data were analyzed using R package (R-4.0.5).
Results: The median TNF-α and MMP-8 concentrations in amniotic fluid from the 145 women included in the study were higher in the FIRS group than in the non-FIRS group. The area under the curve of TNF-α and MMP-8 was 0.77 and 0.75, respectively. The TNF-α concentration cut-off predicting FIRS was 89.20 pg/ml and was 170.76 pg/ml for MMP-8. In regression analysis, MMP-8 concentration was an independent predictor for FIRS. An MMP-8 concentration greater than 170 ng/ml and a TNF-α concentration greater than 89 pg/ml increased the odds of FIRS 7.62 and 14.92 times, respectively.
Conclusions: MMP-8 and TNF-α concentrations in vaginally obtained amniotic fluid may be good predictors for FIRS after PPROM before 34 weeks of pregnancy. The non-invasive amniotic fluid analysis could be an alternative method to invasive amniocentesis.
Gulbiniene V, Dumalakiene I, Balciuniene G, Pilypiene I, Narkeviciute I, Novickij V BMC Pregnancy Childbirth. 2024; 24(1):54.
PMID: 38200448 PMC: 10782524. DOI: 10.1186/s12884-023-06221-0.
Functional MRI assessment of the lungs in fetuses that deliver very Preterm: An MRI pilot study.
Avena-Zampieri C, Hutter J, Uus A, Deprez M, Payette K, Hall M Eur J Obstet Gynecol Reprod Biol. 2023; 293:106-114.
PMID: 38141484 PMC: 10929943. DOI: 10.1016/j.ejogrb.2023.12.015.
Gulbiniene V, Balciuniene G, Dumalakiene I, Viliene R, Pilypiene I, Ramasauskaite D Int J Gynaecol Obstet. 2022; 160(2):476-482.
PMID: 36151969 PMC: 10092754. DOI: 10.1002/ijgo.14478.